To this end, we isolated TDEs from NSCLC patients that harbored either a WT or MT version of the KRAS gene, incubated them with naïve CD4+ CD25− T cells as described above and determined the frequency of CD4+ FOXP3+ cells by flow cytometry. This evidence concerns the gene FOXP3 and non-small cell lung carcinoma.